"I started having red eyes. After the third day of not seeing any progress (I thought I had allergies). I went to the doctor for a diagnosis to find out I had "pink eye". He prescribed me Patanol to control the redness and told me to just wait as "pink eye" is a virus and will go away on its own. I decided to still buy the prescription to find out it cost $160 for 5ml tiny bottle! I used it twice a day (as prescribed) and my eyes were back to its normal white shade in couple of days. I never heard of this eye drop. It is really expensive but seems to be worthy."
We respond promptly to all investment proposals. If our initial review supports continued consideration of an investment proposal, we meet with the management team to discuss the company, industry, and opportunity. We understand the frustrations associated with selling, recapitalizing, and financing a business. At Argosy Private Equity, you will interact directly with experienced, knowledgeable decision makers – not with bureaucracies and committees requiring multiple layers of approvals. Upon making a commitment, we dedicate the resources required to manage the process professionally and efficiently to a timely close. Our reputation has been built on integrity – when we make a commitment, we honor it.
Olopatadine is an antihistamine (as well as anticholinergic and mast cell stabilizer), sold as a prescription eye drop manufactured by Alcon in one of three strengths: % solution or Pazeo in the United States , % solution or Pataday (also called Patanol S in some countries), and % or Patanol (also called Opatanol in some countries; Olopat in India). It is used to treat itching associated with allergic conjunctivitis (eye allergies ).  A steroid-free  nasal spray formulation is sold as Patanase , which was approved by the FDA on April 15, 2008.  It is also available as an oral tablet in Japan under the tradename Allelock , manufactured by Kyowa Hakko Kogyo.